December 19, 2018 / 8:45 AM / 6 months ago

Bristol-Myers gets $1.6 bln offer for French consumer health unit

Dec 19 (Reuters) - Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company’s French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

The offer by Taisho is structured in the form of a “put option” agreement, the companies said.

Bristol-Myers said it estimates the potential deal would be approximately $0.04 dilutive to 2019 earnings. (Reporting by Rama Venkat in Bengaluru; Editing by Sunil Nair)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below